Taiwan to start clinical trials on antiviral drug remdesivir
Taipei, Feb. 26 (CNA) National Taiwan University Hospital (NTUH) has consulted with the United States and is to start clinical trials in Taiwan of the antiviral drug remdesivir for the treatment of COVID-19 coronavirus, the Central Epidemic Command Center (CECC) said Wednesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Taiwan sees 10 new domestic cases, including 1 disease control staff01/16/2022 05:37 PM
Magnitude 5.5 earthquake jolts eastern Taiwan01/16/2022 04:40 PM
Taiwan, Lithuania ties evolve in face of Chinese pressure01/16/2022 03:56 PM
Tonga volcanic eruption tsunami extremely unlikely to reach Taiwan: CWB01/16/2022 03:53 PM